Insiders · Profile

Jiang Wenbin

President and CEO at Cytek Biosciences. Filing since 7 Feb 2022. CIK 0001872873

Company
Date
Role
Action
Shares
Amount
Of holding
7 Nov 2023
President and CEO
Sold at will
20,000
$86.80K
0.4%
9 Oct 2023
President and CEO
Sold on a plan
20,000
$106.60K
0.4%
7 Sep 2023
President and CEO
Sold at will
20,000
$136.60K
0.3%
7 Aug 2023
President and CEO
Sold at will
20,000
$180.80K
0.3%
7 Jul 2023
President and CEO
Sold on a plan
20,000
$169.60K
0.3%
7 Jun 2023
President and CEO
Sold on a plan
20,000
$164.60K
0.3%
8 May 2023
President and CEO
Sold on a plan
20,000
$231.00K
0.3%
10 Apr 2023
President and CEO
Sold on a plan
20,000
$177.60K
0.3%
7 Mar 2023
President and CEO
Sold, plan not stated
20,000
$202.60K
0.3%
7 Feb 2023
President and CEO
Sold, plan not stated
20,000
$263.80K
0.3%
9 Jan 2023
President and CEO
Sold, plan not stated
20,000
$213.20K
0.3%
7 Dec 2022
President and CEO
Sold, plan not stated
20,000
$237.20K
0.3%
7 Nov 2022
President and CEO
Sold, plan not stated
20,000
$295.20K
0.3%
7 Oct 2022
President and CEO
Sold, plan not stated
20,000
$295.80K
0.3%
7 Sep 2022
President and CEO
Sold, plan not stated
20,000
$257.80K
0.3%
8 Aug 2022
President and CEO
Sold, plan not stated
20,000
$301.80K
0.3%
7 Jul 2022
President and CEO
Sold, plan not stated
20,000
$223.80K
0.3%
7 Jun 2022
President and CEO
Sold, plan not stated
20,000
$215.00K
0.3%
9 May 2022
President and CEO
Sold, plan not stated
20,000
$160.20K
0.3%
7 Apr 2022
President and CEO
Sold, plan not stated
20,000
$210.80K
0.3%
7 Mar 2022
President and CEO
Sold, plan not stated
20,000
$253.05K
0.3%
7 Feb 2022
President and CEO
Sold, plan not stated
20,000
$288.00K
0.3%
22 decisions on file.